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Introduction: Endorectal ultrasound (ERU) is used for locoregional staging of rectal cancer. Our work
compares the data in the literature regarding diagnostic accuracy of the technique and results of routine
use of the technique in two centers in Piedmont.Material and methods: 77 reports ultrasound with the
ﬁnal diagnosis of rectal cancer from the period 2008e2012 were examined. The echographies were
performed by two experienced operators, using two ultrasound device with the same technical char-
acteristics. Results: Sensitivity levels are high, with the exception of stage T3. Speciﬁcity is always high.
The relationships of verisimilitude, both negative and positive, showing that the accuracy of the test is
still high. The risk of overstaging is higher for pT1, while most important the risk of understaging
concerns the stage T3 (23.5%); on the contrary the ERU is able to exclude inﬁltration of perirectal organs
with a good accuracy (NPV of 99.3%). Conclusion: Although our study was a retrospective study, likewise
some literature's reports, the interpretation of our analysis results shows a signiﬁcant risk of down-
staging T3 and Nþ tumors. ERU represents in our experience a very important radiological staging
methods to evaluate T1 and T2 rectal cancer.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Subperitoneal rectal cancer is about 35% of cases of colorectal
cancer (CRC) in Europe. Incidence and mortality are of 15e25/
100.000/year and 4e10/100.000/year; the highest rates are recor-
ded in males [1].
Preoperative staging relies on clinical evaluation and on endo-
scopic and imaging techniques. Endorectal ultrasound (ERU) is aC, colorectal cancer; TEM,
rectal excision.
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subperitoneal adjacent structures; together with the MRI is the
investigation of choice for preoperative local staging of rectal
cancer.
ERU was introduced in 1956 by Wild and Reid for the study of
prostate cancer [2]; ten years after the technique was also applied
to the study of the rectum [3,4]. Since then, ERU became more and
more widespread, now becoming the gold standard for rectal
cancer locoregional staging because of its feasibility and minimal
disturbance to the patient [5].
Review of literature shows conﬂicting results on ERU accuracy,
since this is an operator-dependent technique; however, in most of
the studies is stressed the high diagnostic accuracy of the technique
[6]. The two major studies published on ERU are the meta-analysis
of Puli (2009), which shows a high diagnostic accuracy, and a
multicenter study (Marusch, 2011) [7]), which differs from the re-
sults of Puli.
The aim of our study is to compare our results with literature
data, to highlight agreements and discrepancies, and highlight the.
Table 1
Qualitative analysis dell'ERU for the parameter T, with the calculation of the risk of over-and underestimation. SENS¼ sensitivity; SPEC¼ speciﬁcity; I.C.¼ conﬁdence interval;
PPV ¼ positive predictive value; NPV ¼ negative predictive value; LR ¼ likelihood ratio.
Stage SENS % [I.C.] SPEC % [I.C.] PPV% [I.C.] NPV% [I.C.] LR þ [I.C.] LR  [I.C.] Overstaging risk Understaging risk
pT0 0.958 [0.699
e0.996]
0.869 [0.766
e0.931]
0.575 [0.364
e0.762]
0.991 [0.921
e0.999]
7.328 [3.873e13.867] 0.048 [0.03
e0.724]
0 [0.51e52.18] 0 [0.51e52.18]
PTis 0.9 [0.463e0.989] 0.993 [0.937
e0.999]
0.9 [0.463e0.989 0.993 [0.937
e0.999]
129.6 [8.06e2083.968] 0.101 [0.007
e1.397]
42.11 [23.06
e63.95]
0 [0.51e52.18]
pT1 0.778 [0.453
e0.937]
0.882 [0.785
e0.939]
0.467 [0.248
e0.699]
0.968 [0.89
e0.991]
6.611 [3.158e13.838] 0.252 [0.074
e0.858]
47.06 [26.02
e69.24]
11.76 [3.58
e34.71]
pT2 0.833 [0.552
e0.953]
0.908 [0.813
e0.957]
0.625 [0.386
e0.815]
0.967 [0.888
e0.991]
9.028 [4.403e20.157] 0.184 [0.052
e0.652]
33.03 [16.29
e56.55]
11.11 [3.38
e33.14]
pT3 0.714 [0.454
e0.883]
0.952 [0.869
e0.984]
0.769 [0.497
e0.918]
0.938 [0.85
e0.975]
15 [4.736e47.512] 0.3 [0.131e0.688] 17.65 [16.29
e41.42]
23.53 [9.69
e47.64]
pT4 0.833 [0.31
e0.982]
0.993 [0.939
e0.999]
0.833 [0.31
e0.982]
0.993 [0.939
e0.999]
123.333 [7.437
e2045.279]
0.168 [0.013
e2.107]
0 [0.51e52.18] 0 [0.51e52.18]
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clinical experience.
2. Materials and method
We retrospectively reviewed the cases operated for rectal cancer
in San Luigi Gonzaga Teaching Hospital in Orbassano and Santa
Croce e Carle Hospital in Cuneo, from January 2008 to June 2012.
Data were aggregated and the header of origin of individual pa-
tients has been cleared to avoid that this was a confounding factor
for subsequent statistical analysis; reports were divided by stage.
3. Sample selection
On 130 patients operated, 117 are staged with the ERU. Only
exclusion criteria was the treatment with neoadjuvant therapy;
applying this limit, the patients included in the study were 77.
The echographies were performed by two experienced opera-
tors as deﬁned in the literature coming from the same school and
with identity setting and reporting: they collaborated for ﬁve years
and for one year compared to blind their reports. The ultrasound
used in the two centers are identical and use a radial probe at a
frequency of 10e13 MHz.
4. Variables
Characteristics of ERU accuracy were estimated by comparing
ultrasound report with the pathological ﬁndings, considered the
gold standard; for staging TNM classiﬁcation was used [8].
N and T parameters were analyzed separately. For T staging,
patients were stratiﬁed by stage. In each stage was conducted
statistical analysis: true positives (in which ultrasound diagnosis
agrees with the anatomo-pathologic examination), false negatives
(classiﬁed by ultrasound at a stage lower than anatomopatology),
false positives (classiﬁed by ultrasonography at a stage higher than
anatomopatology) and true negatives (patients correctly staged by
ultrasonography as belonging to a different stage than that taken
considered) were identiﬁed.
5. Statistical analysis
Sensitivity, speciﬁcity, positive and negative predictive value,
positive and negative likelihood ratio, with conﬁdence intervals at
95% were estimated [9]. The signiﬁcance of the results was esti-
mated by chi-square test.
Probability to overestimate of ultrasound stage was estimated,
using a logistic regression model where the dependent variable is
the probability of overestimation and the explanatory variables aresensitivity, speciﬁcity, positive predictive value (PPV), negative
predictive value (NPV), positive likelihood ratio (LRþ) and negative
likelihood ratio (LR) [10].
Overestimation Odds ratio, relative conﬁdence intervals of 95%
and signiﬁcance tests was calculated.
All analyzes were conducted with SAS 8.1 program.6. Results
77 ERUs reports were divided as follows: 14 UT0, 6 UTIs, 16 UT1,
UT2 17, 19 UT3, 5 UT4 (total uT ¼ 77); UN0 52, 16 þ uN (uN
total ¼ 68). The number of patients studied for the parameter N is
lower than in patients studied for parameter T because 9 patients
staged as UT0 have not been evaluated by the parameter N.
Table 1 presents the characteristics of accuracy compared ERU
pathological examination in the T staging of the tumor, stratiﬁed by
stage.
Results show levels of sensitivity in accord with literature, with
the exception of pT3 in which the sensitivity does not reach 80%.
The speciﬁcity is still high: the highest value is found for stage pT4
(99.3%), while the speciﬁcity for the stadium PT0 is only 88.2%. The
highest risk of overstaging concerns the pT1. The positive predictive
values are always moderately low, except for pTis, while negative
values are high. The likelihood ratio both negative and positive
show that the accuracy of the test is high. Due to the low sample
size, conﬁdence intervals at 95% are very large.
Speciﬁcity, PPV and LRþ for stage Tis are high (99.3%, 0.9 and
129.6 respectively).
LR-of pT0 stadium is 0.048: the risk that a tumor of the major
stage is identiﬁed as UT0 is therefore very low. However, the risk of
overstaging for pTo is 42%.
Speciﬁcity and LRþ for T1 stadium are respectively 88.2% and
6.611. The PPV is low (0.467), with high risk of overstaging (47%),
but low risk of understaging for T2 (11%).
Sensitivity and speciﬁcity for pT2 stage are respectively 83% and
91%. In this case, the main risk is the overstadiation (33%). The risk
of understadiation is 11%.
T3 stage has low sensitivity (71.4%), high speciﬁcity (95%) and
high NPV (94%). The understaging risk is high (23.5%), conversely
the risk of overstaging (17.65%).
For stage T4 there is a high ability of the test to deﬁne the true
positives (speciﬁcity ¼ 99%; PPV ¼ 83.3%); Furthermore the ERU is
able to exclude the inﬁltration of perirectal organs (NPV ¼ 99.3%).
Evaluation of these variables has also been applied to the
parameter N. Sensitivity and speciﬁcity for pN0 stage are 84%, and
99%. Sensitivity and speciﬁcity for pNþ stage are 95.5%, and 91.4%.
The PPV for N0 and N1 is elevated (98% and 62% respectively). LR-
for Nþ is 0.05, furthermore LRþ is high for both N0 and Nþ (82%
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(37.5%), furthermore overstaging risk is 14.2%.7. Discussion
The main limitation of our study is the low sample size (77
patients). However, our work has an important strength: ultra-
sound scans were performed by only two operators, with over-
lapping manner of reporting. In this way only the minimum bias
linked to the aggregation of reports drawn up by different opera-
tors, considering an operator-dependent technique such as
ultrasound.
We compared the data of our statistical analysis with the main
meta-analysis deal with ERU in the literature [6] and with the
multi-center study that seems to contradict its results [7]; we have
obtained intermediate values of sensitivity for all stages. Sensitivity
for pT2 found in our analysis is greater. Regarding the values of
speciﬁcity, our analysis shows higher values than the analysis of
Puli andMarusch for stage pT3, lower values for pT1, middle for pT2
stage; for stage pT4 the three values are similar.
Our analysis shows that ERU is a technique sensitive enough,
with high levels of speciﬁcity for the parameter T. Main clinical
signiﬁcance deal with relative risk pT1 and pT3 tumors, the limits
for the indication of TEM (Transanal Endoscopic Microsurgery)
[11,12] and neoadjuvant therapy, respectively.
Regarding stage T1, ERU shows a discrete sensitivity (78%) and
good speciﬁcity (88%). Risk of overestimation for T1 is high
(42.11%): its reﬂects the habit of overstaging a dubious tumor for
avoiding the risk of under-treatment. Risk of understaging T2 lesion
is 11%: risk of performing TEM for a patient in an advanced stage, isFig. 1. a) b) c) d): Cranio-caudal progression of the probe that highlights how the loop intherefore low; anyway, ERU is currently the most accurate diag-
nostic technique for T1 stage, as conﬁrmed by the literature [13].
Data analysis for pT3 tumors showed a signiﬁcant risk of
understaging (23.53%), in agreement with the literature [11,14]. For
both T2 and T3 stage surgical treatment of choice is TME; the cor-
rect preoperative staging of T3 tumors refers the patient to neo-
adjuvant therapy, if comorbidities allow. For this reason, the risk of
understaging of almost 24%, as indicated by our analysis, required a
retrospective analysis of understaged cases to improve diagnostic
accuracy of our technique: our attention is focused on cases of pT3
understaged (4 patients) and pNþ false negatives (6 patients). From
this analysis, it appears that errors are correlated to:
 33% ¼ technique errors:
B Limited inﬂation of the probe cover has made the layers of
the rectal wall hardly distinguishable from each other.
B the partial three-dimensional reconstruction of a more cra-
nial peritumoral lymph node than the cancer did not permit a
complete evaluation of the same.
 17%¼ tumor site: the higher lesions can not be studied by ERU in
their proximal portion, making incomplete evaluation of pari-
etal inﬁltration.
 17% ¼ tumor stage: initial inﬁltration of subserosal has been
interpreted as uT2.
 33% ¼ interpretation:
B The operator has not identiﬁed an ileal loop which, occu-
pying the pouch of Douglas, made contact with hypoechoicDouglas comes into contact with the wall of the rectum, looking like in continuity.
Fig. 2. The lymph node visible at 7 o'clock (arrow) appears hypoechoic, homogeneous
with irregular margins (positive criteria for lymph node metastasis); however, is of
3 mm, oval and inhomogeneous (negative criteria for lymph node metastasis).
A. Surace et al. / International Journal of Surgery 12 (2014) S99eS102S102image of tumor. It looks like an image of continuity between
ileal wall and rectal wall inﬁltrated by the tumor, which
creates false layers of the wall, causing understaging (Fig. 1).
B Incorrect assessment of a lymph node as reactive. The char-
acteristics of the lymph nodewere: oval shape, size o2-3mm,
hypoechoic structure and irregular margins, so only 2 of the 5
criteria of malignancy were satisﬁed (Fig. 2).
The accuracy of ERU identifying the inﬁltration of the organs
adjacent to the rectum is, however, satisfactory, with sensitivity
values of 83.3% and speciﬁcity of 99.3%: this allows efﬁcient plan-
ning of surgery.
The criteria used to distinguish a metastatic lymph node from a
reactive lymph node are not sensitive enough, especially for the
initial stages of invasion: risk of understaging is high (37.5%).
In conclusion, the results of ERU in the staging of rectal cancer
are highly variable depending on the operator that performs the
investigation: it is important to periodically compare the inter-
pretation of ultrasound with histological examination of the sur-
gical specimen, to identify the most common errors and improve,
so, their diagnostic accuracy.
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